We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Cohort Plc | CHRT | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
580.00 | 580.00 | 594.00 | 590.00 | 590.00 |
Industry Sector |
---|
AEROSPACE & DEFENCE |
Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
---|---|---|---|---|---|---|
13/12/2023 | Interim | GBP | 0.047 | 04/01/2024 | 05/01/2024 | 13/02/2024 |
19/07/2023 | Final | GBP | 0.0915 | 24/08/2023 | 25/08/2023 | 03/10/2023 |
14/12/2022 | Interim | GBP | 0.0425 | 05/01/2023 | 06/01/2023 | 14/02/2023 |
28/07/2022 | Final | GBP | 0.0835 | 25/08/2022 | 26/08/2022 | 04/10/2022 |
14/12/2021 | Interim | GBP | 0.0385 | 06/01/2022 | 07/01/2022 | 14/02/2022 |
10/12/2020 | Final | GBP | 0.076 | 19/08/2021 | 20/08/2021 | 27/09/2021 |
10/12/2020 | Interim | GBP | 0.035 | 17/12/2020 | 18/12/2020 | 04/02/2021 |
12/12/2019 | Final | GBP | 0.069 | 13/08/2020 | 14/08/2020 | 18/09/2020 |
12/12/2019 | Interim | GBP | 0.032 | 30/01/2020 | 31/01/2020 | 26/02/2020 |
04/01/2019 | Final | GBP | 0.0625 | 22/08/2019 | 23/08/2019 | 18/09/2019 |
Top Posts |
---|
Posted at 21/2/2024 15:03 by shaker45 Defence budgets globally are increasing. Chrt has more upside than downside imo |
Posted at 13/12/2023 07:33 by edmonda "Strong H1 24 results backed by a record order book"For the six months to 31 October 2023 Cohort reported revenue of £94.3m, +22%YoY, EBIT (adj.) of £6.0m, +20%YoY and (adj.) EPS of 10.36p (adj. dil., 10.33p). The closing order book further increased to £353.9m (FY23, £329.1m). With £90m of orders deliverable in H2 the Group reports that 95% of market consensus revenue outlook is covered, whilst the order book has longevity to 2033. The net cash position was £13.3m compared to £15.6m at year-end FY23 and H1 23 net debt of £0.6m boosted by operating cashflow of £10.3m (H1 23: £7.7m). The Group raised the Interim dividend by 10% to 4.70p/share, maintaining the track record of progressive returns. Cohort noted revenue growth in each division underpinned by UK MOD demand. Revenue in the Communications & Intelligence (C&I) division (EID, MASS and MCL) increased 32.3%YoY to £43.9m (46.3% of total). Revenue in the Sensors & Effectors (S&E) division (Chess Dynamics, ELAC Sonar and SEA) grew 14.7%YoY to £51.0m (53.7% of total). Overall, these results confirm the all-important upward trend in orders and contract awards which in turn underpin revenue growth and visibility from operations which span the major theatres of defence operations. These interim results continue the pattern of order-led demand for Cohort’s expertise and services, linking the bigger picture issues that focus on defence to Group prospects. Our Fair Value remains at 650p/share. Link to report: |
Posted at 27/9/2023 19:38 by tole https://masterinvest |
Posted at 21/7/2023 07:32 by edmonda after record results and a 10% dividend increase, Equity Dev raises FY24 forecasts. With a strategically firm defence outlook, fair value is seen at 650p/share.As you can read in a detailed new rsearch note, free access here: PS webinar today Friday 21st at 11am , see registration link on prior post |
Posted at 19/7/2023 11:41 by km18 Cohort plc posted Prelims for FY23 ended 30th April 2023 this morning. Revenue was up 33% to a record £182.7m, adjusted operating profit was up 23% to a new record £19.1m. Adjusted EPS was up a healthy 17% to 36.48p. Growth was broad-based across both divisions but was particularly strong in Communications and Intelligence. The balance sheet remains solid with net funds higher than market expectations at £15.6m given continuing robust cash generation. The dividend was increased 10% to 13.4p and has been raised every year since the Group’s IPO in 2006. Profitability ratios are top quartile for the sector, valuation is reasonably attractive with forward PE ratio 12.4x and top third for the Software & IT Services sector. Share price has been drifting lower for over 3 years now and there is no obvious rush to buy. But the share pays a decent dividend yield at 3.3% and could outperform through a cyclical economic slowdown given the nature of the business. Certainly a share worth monitoring for the time being......from WealthOracle |
Posted at 09/5/2023 08:46 by edmonda And another win: £26.2m upgrade contract for export customer won by subsidiary @SEA_Limited 🙌As CHRT CEO says 'This contract is another significant win for SEA and further underpins our order book and enhances the visibility of future revenues' Latest ED note commented on orders momentum and set Fair Value at 650p / share. Free access to research notes here: |
Posted at 22/3/2023 16:41 by wad collector That would be a fair lump of the £137m turnover last year. And hopefully a profitable contract as well as a large one for CHRT. Will it trigger some more broker tipping? |
Posted at 15/12/2022 07:59 by edmonda For the six months to 31 October 2022, Cohort plc reported a strong performance: revenue was up 29%YoY to £77.5m; an operating profit (adj.) of £5.0m was achieved (H1 22: £1.7m); and EBITDA (adj.) was £7.1m. Order intake of £88.6m resulted in a record closing order book of £304.2m. The interim dividend is raised 10% to 4.25p/share.Absorption of working capital meant that H1 net debt was £0.6m; however, Cohort reports that as of 9th December net funds were £7.6m. Added to H1 revenue, over £80m of orders deliverable in the second-half equates to 95% coverage of our revised full year revenue outlook of £165.0m. A strong interim performance, in particular by MCL, supports an increase in our FY23 revenue outlook of 3%, to £165m, growth of 19.9%YoY; while our EBITDA (adj.) outlook remains at £22.0m (up 13.1%YoY). We maintain our Fair Value of 650p/share. |
Posted at 14/12/2022 12:14 by kalai1 Cohort plc posted Interims for the 6 months ended 31st October this morning which reported a much stronger first half for the Group with a record closing order book. Revenues were up 29% to £77.5m, adjusted operating profit was up significantly to £5.0m and adjusted EPS up to 10.12p (2021: 3.04p). The record closing order book reached £304.2m and the interim dividend was increased by 10% to 4.25p. Valuation is relatively attractive with forward PE at 11.6x, the balance sheet is solid. Share price has been drifting sideways or lower for nearly 3 years and lacks momentum. Ongoing solid business performance could act as a catalyst for some renewed share price appreciation, but there is no rush to buy. CHRT is a share to monitor for now......from WealthOracle |
Posted at 25/8/2022 06:35 by terminator101 Pretty decent. Profited up and dividend up 10% ;-) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |